Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 102

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 102
---
 to Aadi pursuant to the terms of the Divestiture Agreement or otherwise. The opinion of Leerink Partners was necessarily based on financial, economic, monetary,
currency, market and other conditions and circumstances as in effect on, and the information made available to Leerink Partners as of, the date of its written opinion, and Leerink Partners does not have any obligation or responsibility to update,
revise or reaffirm its opinion based on circumstances, developments or events occurring after the date of the opinion. Leerink Partners’ opinion does not constitute a recommendation to any stockholder of Aadi as to whether or how such
stockholder should vote or otherwise act with respect to the Divestiture or any other matter.

Leerink Partners’ financial advisory
services and its opinion were provided for the information and assistance of Aadi’s board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of its consideration of the
Divestiture. Leerink Partners’ opinion was approved by the Leerink Partners LLC Fairness Opinion Review Committee.

Summary of Financial Analyses

The following is a summary of the material financial analyses prepared by Leerink Partners and reviewed with Aadi’s board of directors in
connection with its opinion, which was delivered orally to Aadi’s board of directors on December 19, 2024, and subsequently confirmed in its written opinion, dated December 19, 2024. For purposes of the analyses described below,
Leerink Partners was directed to rely upon the Internal Data, including the Aadi Projections. The summary set forth below does not purport to be a complete description of the financial analyses performed or factors considered by, and underlying the
opinion of, Leerink Partners, nor does the order of the analyses described below represent the relative importance or weight given to those analyses by Leerink Partners. The preparation of a fairness opinion is a complex analytical process involving
various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a fairness opinion is not readily susceptible to summary description.
In arriving at its opinion, Leerink Partners did not draw, in isolation, conclusions from or with regard to any factor or analysis that it considered. Accordingly, Leerink Partners believes that its analyses must be considered as a whole and that
selecting portions of such analyses and factors without considering all analyses and factors, could create a misleading or incomplete view of the processes underlying Leerink Partners’ financial analyses